Rheumnow Podcast

- QD232 - Bad Habits with Rheumatoid Factor  https://youtu.be/xwGTYYBP6Oc - QD233 - RA - GI Fast Track https://youtu.be/E6lKWJf7fOM - QD234 - RA and Breast Cancer   https://youtu.be/lyulIohG5F0 - QD235 - RA in Deep Remission   https://youtu.be/VzxNnIUnmvU

This Tuesday Night Rheumatology panel discusses "DMARD Choices & Changes", including weaning, biosimilars, and guideline views from a panel that includes Drs. Madelaine Feldman, Alan Matsumoto, Artie Kavanaugh and Jack Cush.​Recorded on 9/16/2023

Dr. Jack Cush is joined by Dr. Michael Weinblatt as they discuss this weeks news and journal reports, including difficult RA, HLA typing and abatacept responses and new regulatory decisions.

  - QD229: Meet the patient where they are  (Dr. E. Dein) https://youtu.be/OWdc6SoHDGo   - QD230: Cardiovascular Risk and RA  (Dr. K. Dao)  https://youtu.be/gjH1oqDlK2Q   - QD231: RA with Eye Problems  (Dr. M. Putman) https://youtu.be/cdopMGbD2ww   - QD232: Enough with the Steroids (Dr. J Cush)   https://youtu.be/cHFUNOtN_JQ

Dr. Michael Weinblatt is a renowned rheumatology expert, accompanied by Grace Wright, a physician skilled in autoimmune diseases, Richard Conway, a treatment methodology authority, and Joel Kremer, a specialist in rheumatic conditions. They delve into the intricacies of methotrexate as a treatment option. Topics include the critical balance of folate supplementation, managing liver health, and the impacts of alcohol on treatment. They also discuss methotrexate's role alongside vaccinations and its use in patients with interstitial lung disease, emphasizing the necessity of careful monitoring and personalized treatment strategies.

 - QD225:  Rheumatoid Arthritis and VTE  (Dr. J Cush) https://youtu.be/K1TzzKmVs5U   - QD226: Older RA Obstacles  (Dr. J Cush) https://youtu.be/jHKPEwcqa0M   - QD227: RA and medication induced ulcers  (Dr. B. Mehta) https://youtu.be/4QUtyz1WGJY   - QD228: Clinic: Induced inflammatory arthritis  (Dr. D. Liew)  https://youtu.be/3LkJKp-iGgk

  - QD221: RA & Vaccination  (Dr. J. Cush) https://youtu.be/6qsz0TPVKLU   - QD222: Goal of the First Visit (Dr. J Cush)  https://youtu.be/EwsO9LCywzI   - QD223: MTX Pearls  (Dr. J Cush) https://youtu.be/fktKlc0Pk-o   - QD224: RA on MTX with Progressive Dyspnea (Dr. R. Conway)  https://youtu.be/g1Q_uG9zZ0g

- Hard Decisions - Debate: Triple DMARD Therapy (Drs. Pope & Wells) https://youtu.be/22NDkYnIUS0 - Hard Decisions: Perspectives: The Future of RA  (Drs. McInnes & Burmester)  https://youtu.be/HoxrZk5FG14 - Hard Decisions - Perspectives: Steroid Use in RA (Drs. Landewe, England, Nash)   https://youtu.be/tcX8GA6xzQw - Hard Decisions: HSV and RSV Update for Rheumatology  (Dr. Winthrop) https://youtu.be/TZVcZW4DvQo

Dr. Troum and Dr. Ruderman delve into the changing landscape of imaging for rheumatoid arthritis, revealing the reduced necessity for annual radiographs and spotlighting the roles of MRI and ultrasound. Dr. Cush discusses the complexities surrounding seropositivity, shedding light on how autoantibody levels impact diagnosis. Dr. Weinblatt emphasizes the pivotal role of methotrexate, discussing optimal dosing and monitoring practices. Lastly, Dr. Kavanaugh addresses the multifaceted challenges of managing difficult-to-treat RA, advocating for personalized treatment strategies.

This week, Dr. Jack Cush reviews the news with special guest, Dr. Peter Nash. They discuss COVID Autoantibodies, SpA life expectancy, HCQ, extraarticular RA and our approach to Early RA referrals and pre-clinical RA.